Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 9/20 | 1.00 |
| ▸ | METAP2 | P50579 | 7/20 | 1.00 |
| ▸ | NPC1 | O15118 | 6/20 | 1.00 |
| ▸ | RAB9A | P51151 | 6/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | FKBP1A | P62942 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiabendazole SCHEMBL19842 | 1.00 | METAP1 (1.00) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL29370729 | 1.00 | METAP1 (1.00) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL5184037 | 0.98 | METAP1 (0.97) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL2314460 | 0.98 | METAP1 (0.97) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL11218788 | 0.98 | METAP1 (0.97) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL7733801 | 0.98 | METAP1 (0.97) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL28861440 | 0.98 | METAP1 (0.97) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL9856779 | 0.98 | METAP1 (0.97) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL675655 | 0.91 | METAP1 (0.83) | METAP1METAP2NPC1RAB9ASMN1; SMN2 | |
| Thiabendazole SCHEMBL675656 | 0.91 | METAP1 (0.83) | METAP1METAP2NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7772009-B2 | Room temperature phosphorescence apparatus and methods | SCR Research, LLC (US) | 2010-08-10 | — | — | US | claimed |
| WO-2007061574-A2 | ROOM TEMPERATURE PHOSPHORESCENCE APPARATUS AND METHODS | SCA RESEARCH, LLC (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070117215-A1 | Room temperature phosphorescence apparatus and methods | POLYMER CONCEPTS TECHNOLOGIES PBY, INC. | 2007-05-24 | — | — | US | claimed |
| CN-109310093-A | Natamycin composition and application thereof | AREC作物保护有限公司 | 2019-02-05 | — | — | CN | disclosed |
| US-9951205-B2 | Stable compositions of thiabendazole and iodine-containing fungicides | LANXESS DEUTSCHLAND GMBH (DE) | 2018-04-24 | — | — | US | disclosed |
| CN-104204057-B | Thiabendazole and the stable compositions containing iodine antifungal | 朗盛德国有限责任公司 | 2016-10-05 | — | — | CN | disclosed |
| US-9296878-B2 | Fungicide formulations for plasticized PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2016-03-29 | — | — | US | disclosed |
| US-20150203660-A1 | FUNGICIDE FORMULATIONS FOR PLASTICIZED PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2015-07-23 | — | — | US | disclosed |
| US-20150051279-A1 | STABLE COMPOSITIONS OF THIABENDAZOLE AND IODINE-CONTAINING FUNGICIDES | LANXESS DEUTSCHLAND GMBH (DE) | 2015-02-19 | — | — | US | disclosed |
| EP-2637501-A2 | FUNGICIDAL COMPOSITIONS AND METHODS OF USE | The Board Of Trustees Of The University Of Alabama (US) | 2013-09-18 | — | — | EP | disclosed |
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-10-18 | — | — | US | disclosed |
| WO-2007061574-A2 | ROOM TEMPERATURE PHOSPHORESCENCE APPARATUS AND METHODS | SCA RESEARCH, LLC (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20070117215-A1 | Room temperature phosphorescence apparatus and methods | POLYMER CONCEPTS TECHNOLOGIES PBY, INC. | 2007-05-24 | — | — | US | disclosed |
| WO-2007044693-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | THE UNIVERSITY OF ALABAMA (US) | 2007-04-19 | — | — | WO | disclosed |
| EP-1375354-A1 | PACKAGED FOOD PRODUCT AND PRODUCTION METHOD THEREFOR | Resticas del Guadalquivir, S.A. (ES) | 2004-01-02 | — | — | EP | disclosed |
| US-5948421-A | Aqueous liquid agricultural composition | KAO CORPORATION (JP) | 1999-09-07 | — | — | US | disclosed |
| US-5757278-A | Personal verification system | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | disclosed |
| WO-1997036471-A1 | GELATIN-BASED COATINGS FOR PLANT SEEDS AND PROPAGULES | MONSANTO COMPANY (US) | 1997-10-09 | — | — | WO | disclosed |
| WO-1996015107-A1 | DITHIOCARBAMATE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-05-23 | — | — | WO | disclosed |
| EP-0617074-A1 | Alveolar cellulose material containing a biocide | FINANCIERE ELYSEES BALZAC (FR) | 1994-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | SLC5A6, PNLIP, IPMK | METAP1 1967/4885METAP2 1443/4885NPC1 295/4885 |
| US-20150051279-A1 | STABLE COMPOSITIONS OF THIABENDAZOLE AND IODINE-CONTAINING FUNGICIDES | DDT, TPO, TRHDE | METAP1 3898/4885METAP2 3357/4885NPC1 3293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.